thyroid cancer glp 1 Do GLP-1 Weight-Loss Shots Really Raise Risk? With the rapid expansion of GLP-1 medications for diabetes and weight loss, public concern has grown regarding a possible link to thyroid cancer Implications of GLP-1 Receptor Agonist

K.BentleyR

This study did not find higher rates of gallstones, often associated with weight loss, with these drugs, and found fewer episodes of ileus, or blocked colon, than expected based on age and other medical conditions

Not instant or permanent : Weight loss is gradual, and stopping the medication often leads to weight regain

By activating both receptors simultaneously, tirzepatide produces stronger appetite suppression, slower gastric emptying, and improved insulin sensitivity than single-hormone GLP-1 agents alone

Whats more, the tumors are usually smaller than an inch in size, making them difficult to locate and diagnose